Dermatologists
6 years of experience

Accepting new patients
West Bloomfield
Ronald D Kerwin, MD
6330 Orchard Lake Rd
Ste 120
West Bloomfield, MI 48322
248-855-3366
Locations and availability (9)

Education ?

Medical School Score Rankings
University of Michigan Medical School (2004)
  • Currently 4 of 4 apples
Top 25%

Awards & Distinctions ?

Associations
American Board of Dermatology
American Society for Dermatologic Surgery

Affiliations ?

Dr. Cetner is affiliated with 14 hospitals.

Hospital Affilations

Score

Rankings

  • Beaumont Hospital,Troy
    44201 Dequindre Rd, Troy, MI 48085
    • Currently 4 of 4 crosses
    Top 25%
  • Beaumont Hospital, Grosse Pointe
    468 Cadieux Rd, Grosse Pointe, MI 48230
    • Currently 4 of 4 crosses
    Top 25%
  • Beaumont Hospital, Royal Oak
    3601 W 13 Mile Rd, Royal Oak, MI 48073
    • Currently 4 of 4 crosses
    Top 25%
  • Huron Valley-Sinai Hospital
    1 William Carls Dr, Commerce Township, MI 48382
    • Currently 4 of 4 crosses
    Top 25%
  • Provena St Joseph Medical Center
    6 Charleston Rd, Hinsdale, IL 60521
    • Currently 4 of 4 crosses
    Top 25%
  • Edward Hospital
    801 S Washington St, Naperville, IL 60540
    • Currently 4 of 4 crosses
    Top 25%
  • Detroit Receiving Hospital & University Health Center
    4201 Saint Antoine St, Detroit, MI 48201
    • Currently 3 of 4 crosses
    Top 50%
  • Silver Cross Hospital
    1200 Maple Rd, Joliet, IL 60432
    • Currently 3 of 4 crosses
    Top 50%
  • University Of Illinois Medical Center At Chicago
    1740 W Taylor St, Chicago, IL 60612
    • Currently 2 of 4 crosses
  • Royal Oak (2 Years
  • Sinai-Grace Hospital
    6071 W Outer Dr, Detroit, MI 48235
  • Provena Saint Joseph Hospital
    77 N Airlite St, Elgin, IL 60123
  • University of Illinois Medical Center at Chicago
  • Royal Oak
  • Publications & Research

    Dr. Cetner has contributed to 3 publications.
    Title Cutaneous Presentation of Plasmablastic Post-transplant Lymphoproliferative Disorder in a 14-month-old.
    Date June 2010
    Journal Pediatric Dermatology
    Excerpt

    We present a 14-month-old female child who developed multiple erythematous nodules on her abdomen 5 months after liver and small bowel transplantation. Skin biopsy revealed a dense infiltrate of large cells in the dermal and subcutaneous layers with frequent mitotic figures. The cells were noted to have abundant cytoplasm, prominent nucleoli, and open chromatin. Immunohistochemical stains were positive for CD138, CD56, Ki67 (>90%), and lambda chain restriction. Rare mature B cells (CD20) and rare T cells (CD3) were noted. She was diagnosed with high-grade post-transplant lymphoproliferative disorder most consistent with plasmablastic lymphoma.

    Title Tuberculosis in the Age of Biologic Therapy.
    Date September 2008
    Journal Journal of the American Academy of Dermatology
    Excerpt

    The introduction of biologic therapies for psoriasis has revolutionized the treatment of plaque psoriasis. These changes in our drug armamentarium have resulted in the need for dermatologists to have a through command of knowledge regarding tuberculosis given the potential for reactivation with this class of medications. The focus of this review is to update dermatologists on pertinent information regarding the microbiology, immunology, screening, and recognition of the clinical presentations of tuberculosis. The current literature regarding the occurrence of tuberculosis with biologics, specifically antitumor necrosis factor therapy, is reviewed. Special emphasis is placed on the different clinical presentations between newly acquired tuberculosis versus reactivation of latent disease while receiving these medications. Given the ever-widening use of biologic therapy in our specialty, we must be capable of rapidly identifying infected patients, including those with asymptomatic latent disease. The failure to screen for tuberculosis before the initiation of biologic therapy may result in adverse outcomes for both the patient and the overall health of our communities.

    Title Refractory Aggressive Keratoacanthoma Centrifugum Marginatum of the Scalp Controlled with the Epidermal Growth Factor Receptor Inhibitor Erlotinib.
    Date
    Journal The British Journal of Dermatology
    Excerpt

    Keratoacanthomas are squamous cell neoplasms known to be abundant in epidermal growth factor receptors (EGFRs). Erlotinib (Tarceva(®); Roche) is a low molecular weight oral quinazoline compound that binds to the intracellular EGFR tyrosine kinase domain and inhibits receptor phosphorylation and downstream signalling. We report a case of refractory, locally aggressive keratoacathoma centrifugum marginatum of the scalp having strong EGFR expression and demonstrating excellent response to erlotinib.


    Similar doctors nearby

    Dr. Ronald Kerwin

    Dermatology
    34 years experience
    West Bloomfield, MI

    Dr. Suzanne Merkle

    Dermatology
    18 years experience
    West Bloomfield, MI

    Dr. D'Anne Kleinsmith

    Dermatology
    34 years experience
    West Bloomfield, MI

    Dr. Roxana Chapman

    Dermatology
    31 years experience
    West Bloomfield, MI

    Dr. Kay Watnick

    Dermatology
    27 years experience
    West Bloomfield, MI

    Dr. Ethan Nydorf

    Dermatology
    32 years experience
    West Bloomfield, MI
    Search All Similar Doctors